JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on August 27, 2004; DOI: 10.1124/jpet.104.071761


0022-3565/04/3113-1188-1202$20.00
JPET 311:1188-1202, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.104.071761v1
311/3/1188    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hadjimarkou, M. M.
Right arrow Articles by Bodnar, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hadjimarkou, M. M.
Right arrow Articles by Bodnar, R. J.

BEHAVIORAL PHARMACOLOGY

Opioid Receptor Involvement in Food Deprivation-Induced Feeding: Evaluation of Selective Antagonist and Antisense Oligodeoxynucleotide Probe Effects in Mice and Rats

M. M. Hadjimarkou, A. Singh, Y. Kandov, Y. Israel, Y.-X. Pan, G. C. Rossi, G. W. Pasternak, and R. J. Bodnar

Department of Psychology and Neuropsychology Doctoral Sub-Program, Queens College, City University of New York, Flushing, New York (M.M.H., A.S., Y.K., Y.I., R.J.B.); Laboratory of Molecular Neuropharmacology, Memorial Sloan-Kettering Cancer Center, New York, New York (Y.-X.P., G.C.R., G.W.P.); and Department of Psychology, C. W. Post College, Long Island University, Brookville, New York (G.C.R.)

Central administration of general and selective opioid receptor subtype antagonists in the rat has revealed a substantial role for µ, a moderate role for {kappa}, and a minimal role for {delta} receptors in the mediation of deprivation-induced feeding. Antisense probes directed against the {kappa} opioid receptor (KOP), nociceptin opioid receptor (NOP), and {delta} opioid receptor (DOP) genes in rats result in reductions similar to {kappa} and {delta} antagonists, whereas antisense probes directed against the µ opioid receptor (MOP) gene produced modest reductions relative to µ antagonists, suggesting that isoforms of the MOP gene may mediate deprivation-induced feeding. Since these isoforms were initially identified in mice, the present study compared the effects of general and selective opioid receptor antagonists on deprivation-induced feeding in rats and mice and antisense probes directed against exons of the MOP, DOP, KOP, and NOP genes on deprivation-induced feeding in the mouse. Food-deprived (12 and 24 h) rats and mice displayed similar profiles of reductions in deprivation-induced feeding following general, µ, and {kappa} opioid antagonists. In contrast, mice, but not rats, displayed reductions in deprivation-induced intake following {delta} antagonism as well as DOP antisense probes, suggesting a species-specific role for the {delta} receptor. Antisense probes directed against the KOP and NOP genes also reduced deprivation-induced intake in mice in a manner similar to {kappa} antagonism. However, the significant reductions in deprivation-induced feeding following antisense probes directed against either exons 2, 4, 7, 8, or 13 of the MOP gene were modest compared with µ antagonism, suggesting a role for multiple µ-mediated mechanisms.


Received June 21, 2004; accepted August 27, 2004.

Address correspondence to: Dr. Richard J. Bodnar, Department of Psychology, Queens College, CUNY, 65-30 Kissena Blvd., Flushing, NY 11367. E-mail: richard_bodnar{at}qc.edu




This article has been cited by other articles:


Home page
Mol. Endocrinol.Home page
T. Wen, B. Peng, and J. E. Pintar
The MOR-1 Opioid Receptor Regulates Glucose Homeostasis by Modulating Insulin Secretion
Mol. Endocrinol., May 1, 2009; 23(5): 671 - 678.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
A. Rizzi, E. C. Gavioli, G. Marzola, B. Spagnolo, S. Zucchini, R. Ciccocioppo, C. Trapella, D. Regoli, and G. Calo

J. Pharmacol. Exp. Ther., June 1, 2007; 321(3): 968 - 974.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics.